Bleomycin Sulfate Glycopeptide Compound with CEP 2025-187 and US DMF 42629 Meeting USP EP Standard
CEP 2025-187 Bleomycin Sulfate
,US DMF 42629 Bleomycin Sulfate
,USP EP Standard Glycopeptide Compound
Original Manufacturer: Hubei Honch Pharmaceutical Co., Ltd.CEP: Available — CEP 2025-187 - Rev 00, Valid (issued 2026-09-02) US DMF: Active — DMF 42629 (Type II, latest filing Nov 2025) FDA Inspection Status: VAI (March 2025) EU GMP / WC: Available — EU Written Confirmation on record Standard: USP / ...
Original Manufacturer: Hubei Honch Pharmaceutical Co., Ltd.
CEP: Available — CEP 2025-187 - Rev 00, Valid (issued 2026-09-02)
US DMF: Active — DMF 42629 (Type II, latest filing Nov 2025)
FDA Inspection Status: VAI (March 2025)
EU GMP / WC: Available — EU Written Confirmation on record
Standard: USP / EP
Annual Capacity: Please contact us for details
Disclaimer: All detailed product information shall be subject to the issued final COA. CEP copies and US DMF Letters of Authorization (LOA) are available to qualified buyers upon request. The manufacturing site's FDA inspection status (VAI, March 2025) is disclosed for buyer awareness. Buyers are responsible for verifying regulatory eligibility for their target market.
